InvestSMART

Compumedics Limited (ASX:CMP)

ALERT: Price-sensitive ASX Announcement for CMP
Current share price for CMP : $0.260 -0.005 (-1.89%)+
Announcement
Release
25 Aug 2026 9:07AM
Price at Release
$0.265
Full Release
download
Summary
Compumedics Limited reported significant growth in FY26, with record revenue of $60.3 million, a 72% increase in EBITDA to $5.4 million, and a return to NPAT profitability with $0.2 million. The company achieved a 70% increase in revenue from its Somfit and Nexus 360 SaaS platforms. MEG contributed $9.7 million to the revenue, marking a significant milestone. The company ended FY26 with $6.6 million in operating cash flow and $5.6 million in cash and equivalents. A $2 million cost savings program was successfully implemented. The outlook for FY27 is optimistic, aiming for further revenue and EBITDA growth, driven by strong sales orders and expanding SaaS platforms.
Key Points
  • Record FY26 revenue of $60.3 million, up 18.5% from FY25
  • EBITDA grew by 72% to $5.4 million
  • Return to NPAT profitability with $0.2 million
  • Somfit and Nexus 360 SaaS revenue increased by 70%
  • MEG contributed $9.7 million to FY26 revenue
  • Operating cash inflow of $6.6 million
  • Cash and equivalents improved to $5.6 million
  • Successful implementation of a $2 million cost savings program
  • Targeting further double-digit revenue and EBITDA growth in FY27
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.